<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37243035</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>03</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Enterovirus 71-Associated Infection in South Vietnam: Vaccination Is a Real Solution.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">931</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines11050931</ELocationID><Abstract><AbstractText>Hand-foot-and-mouth disease (HFMD) is the most common enteroviral infection in South-East Asia. When evaluating the role of enterovirus 71 (EVA71) as an etiological agent of infectious disease in South Vietnam, we revealed a high proportion of EVA71 among identified species A enteroviruses found in 3542 samples from HFMD cases; 125 samples from cases of enteroviral meningitis; and 130 samples from acute flaccid paralysis (AFP) cases. These represent 50%, 54.8%, and 51.5%, respectively. According to molecular analysis, 90% of EVA71 were attributed to genotype C4 and 10% were attributed to genotype B5. The predominance of EVA71 circulation among the population proves the need to strengthen surveillance (with monitoring of enterovirus circulation for facilitation of HFMD outbreak prediction) and to increase the effectiveness of preventative measures by the implementation of vaccination against EVA71-associated infections. A phase III trial of a Taiwanese vaccine (EV71vac) in Taiwan and South Vietnam showed its safety, tolerability, and efficacy in children aged 2-71 months. This B4 genotype-based vaccine, which features cross-protection against B5 and C4 genotypes, and other existing EV71 vaccines can serve as a good approach to solving the HFMD problem, which is so important for Vietnam.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romanenkova</LastName><ForeName>Natalia I</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>Saint Petersburg Pasteur Institute, St. Petersburg 197101, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Thi Thanh Thao</ForeName><Initials>TTT</Initials><AffiliationInfo><Affiliation>Pasteur Institute, Ho Chi Minh City 167 Pasteur, Phường Võ Thị Sáu, Quận 3, TP. Hồ Chí Minh 643103, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golitsyna</LastName><ForeName>Liudmila N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Blokhina Nizhny Novgorod Research Institute of Epidemiology and Microbiology, Nizhny Novgorod 603950, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ponomareva</LastName><ForeName>Natalia V</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>Blokhina Nizhny Novgorod Research Institute of Epidemiology and Microbiology, Nizhny Novgorod 603950, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rozaeva</LastName><ForeName>Nadezhda R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Saint Petersburg Pasteur Institute, St. Petersburg 197101, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanaeva</LastName><ForeName>Olga I</ForeName><Initials>OI</Initials><AffiliationInfo><Affiliation>Saint Petersburg Pasteur Institute, St. Petersburg 197101, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leonov</LastName><ForeName>Artem V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Blokhina Nizhny Novgorod Research Institute of Epidemiology and Microbiology, Nizhny Novgorod 603950, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novikova</LastName><ForeName>Nadezhda A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Blokhina Nizhny Novgorod Research Institute of Epidemiology and Microbiology, Nizhny Novgorod 603950, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bichurina</LastName><ForeName>Maina A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Saint Petersburg Pasteur Institute, St. Petersburg 197101, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute flaccid paralysis</Keyword><Keyword MajorTopicYN="N">circulation</Keyword><Keyword MajorTopicYN="N">enteroviral meningitis</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">hand-foot-and-mouth disease</Keyword><Keyword MajorTopicYN="N">non-polio enterovirus 71 vaccine</Keyword><Keyword MajorTopicYN="N">prevention</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>1</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37243035</ArticleId><ArticleId IdType="pmc">PMC10221170</ArticleId><ArticleId IdType="doi">10.3390/vaccines11050931</ArticleId><ArticleId IdType="pii">vaccines11050931</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akhmadishina L.V., Govorukhina M.V., Kovalev E.V., Nenadskaya S.A., Ivanova O.E., Lukashev A.N. Enterovirus A71 Meningoencephalitis Outbreak, Rostov-on-Don, Russia, 2013. Emerg. Infect. Dis. 2015;21:1440–1443. doi: 10.3201/eid2108.141084.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2108.141084</ArticleId><ArticleId IdType="pmc">PMC4517719</ArticleId><ArticleId IdType="pubmed">26196217</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L., Gao F., Mao Q., Sun S., Wu X., Liu S., Yang X., Liang Z. Hand, foot, and mouth disease associated with coxsackievirus A10: More serious than it seems. Expert Rev. Anti-infective Ther. 2019;17:233–242. doi: 10.1080/14787210.2019.1585242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2019.1585242</ArticleId><ArticleId IdType="pubmed">30793637</ArticleId></ArticleIdList></Reference><Reference><Citation>Donato C., Hoi L.T., Hoa N.T., Hoa T.M., Van Duyet L., Ngan T.T.D., Van Kinh N., Trung N.V., Vijaykrishna D. Genetic characterization of Enterovirus 71 strains circulating in Vietnam in 2012. Virology. 2016;495:1–9. doi: 10.1016/j.virol.2016.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.04.026</ArticleId><ArticleId IdType="pubmed">27148893</ArticleId></ArticleIdList></Reference><Reference><Citation>Golitsyna L., Zverev V., Selivanova S., Ponomareva N., Kashnikov A., Sozonov D., Sashina T., Epifanova N., Evplova I., Rezaykin A., et al. Etiological Structure of Enterovirus Infections in the Russian Federation in 2017–2018. Public Health Life Environ. (PH&amp;LE) 2019;8:30–38. doi: 10.35627/2219-5238/2019-317-8-30-38.</Citation><ArticleIdList><ArticleId IdType="doi">10.35627/2219-5238/2019-317-8-30-38</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukashev A.N., Reznik V.I., Ivanova O.E., Eremeeva T.P., Karavianskaia T.N., Pereskokova M.A., Lebedeva L.A., Lashkevich V.A., Mikhaĭlov M.I. Molecular epidemiology of virus ECHO 6—The etiological agent of men-ingitis outbreak in Khabarovsk in 2006. Vopr. Virusol. 2008;53:16–21.</Citation><ArticleIdList><ArticleId IdType="pubmed">18318129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukashev A.N., Ivanova O.E., Eremeeva T.P., Gmyl L.V. Analysis of echovirus 30 isolates from Russia and new independent states revealing frequent recombination and reemergence of ancient lineages. J. Clin. Microbiol. 2008;46:665–670. doi: 10.1128/JCM.02386-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02386-06</ArticleId><ArticleId IdType="pmc">PMC2238089</ArticleId><ArticleId IdType="pubmed">18077646</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.T., Pham H., Hoang C.Q., Nguyen T.M., Nguyen L.T., Phan H.C., Phan L.T., Vu L.N., Minh N.N.T. Epidemiological and clinical characteristics of children who died from hand, foot and mouth disease in Vietnam, 2011. BMC Infect. Dis. 2014;14:341. doi: 10.1186/1471-2334-14-341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-341</ArticleId><ArticleId IdType="pmc">PMC4068316</ArticleId><ArticleId IdType="pubmed">24942066</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.T., Vu T.T., Phạm M.T., Tran Q.K., Hoang Q.C. Circulation of Coxsackievirus a in Handfoot-Mouth Disease in Southern Vietnam, 2015–2016. Russ. J. Infect. Immun. 2018;8:533. doi: 10.15789/2220-7619-2018-4-3.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.15789/2220-7619-2018-4-3.35</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tu P., Thao N.T.T., Perera D., Truong K.H., Tien N.T.K., Thuong T.C., How O.M., Cardosa M.J., McMinn P.C. Epidemiologic and Virologic Investigation of Hand, Foot, and Mouth Disease, Southern Vietnam, 2005. Emerg. Infect. Dis. 2007;13:1733–1741. doi: 10.3201/eid1311.070632.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1311.070632</ArticleId><ArticleId IdType="pmc">PMC3375788</ArticleId><ArticleId IdType="pubmed">18217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanenkova N.I., Rozaeva N.R., Bichurina M.A., Kanaeva O.I., Chkhyndzheriya I.G., Shishkina L.V., Madoyan A.G., Valdaitseva N.V. Epidemiological aspects of enterovirus infection in the Russian Federation during the period of 2018–2019. J. Infectology. 2021;13:108–116. doi: 10.22625/2072-6732-2021-13-1-108-116.</Citation><ArticleIdList><ArticleId IdType="doi">10.22625/2072-6732-2021-13-1-108-116</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanenkova N.I., Golitsyna L.N., Nguyen T.T.T., Ponomareva N.V., Leonov A.V., Kanaeva O.I., Zverev V.V., Selivanova S.G., Rozaeva N.R., Luong M.T., et al. Epidemiological and etiological aspects of enterovirus infection in Russia and Vietnam. Russ. J. Infect. Immun. 2021;11:905–916. doi: 10.15789/2220-7619-EAE-1791.</Citation><ArticleIdList><ArticleId IdType="doi">10.15789/2220-7619-EAE-1791</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H., Gao M., Cui D. Molecular characteristics of the VP1 region of enterovirus 71 strains in China. Gut Pathog. 2020;12:1–11. doi: 10.1186/s13099-020-00377-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-020-00377-2</ArticleId><ArticleId IdType="pmc">PMC7427758</ArticleId><ArticleId IdType="pubmed">32818043</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan C.H., Nguyen T.P.T., Doan N.M.Q., Nguyen T.T.T., Nguyen Q.H., Tran A.T., Nguyen Q.K., Kiem S.H., Hoang T.L., Vu T.H.T., et al. Epidemiological characteristic of hand, foot and mouth disease in the south of Vietnam, 2010–2012. J. Prev. Med. 2013;T.23:172.</Citation></Reference><Reference><Citation>Thao N.T.T., Donato C., Trang V.T.H., Kien N.T., Trang P.M.T., Khanh T.Q., Nguyet D.T., Sessions O.M., Cuong H.Q., Lan P.T., et al. Evolution and Spatiotemporal Dynamics of Enterovirus A71 Subgenogroups in Vietnam. J. Infect. Dis. 2017;216:1371–1379. doi: 10.1093/infdis/jix500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix500</ArticleId><ArticleId IdType="pmc">PMC5853389</ArticleId><ArticleId IdType="pubmed">29029128</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoa L.P.K., Chiang P.-S., Khanh T.H., Luo S.-T., Dan T.N.H., Wang Y.-F., Thuong T.C., Chung W.-Y., Hung N.T., Wang J.-R., et al. Genetic and Antigenic Characterization of Enterovirus 71 in Ho Chi Minh City, Vietnam, 2011. PLoS ONE. 2013;8:e69895. doi: 10.1371/journal.pone.0069895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0069895</ArticleId><ArticleId IdType="pmc">PMC3726754</ArticleId><ArticleId IdType="pubmed">23922846</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) Manual for the Virological Investigation of Polio. 4th ed. WHO; Geneva, Switzerland: 2004. pp. 1–112.</Citation></Reference><Reference><Citation>World Health Organization (WHO)  A Guide to Clinical Management and Public Health Response for Hand, Foot and Mouth Disease (HFMD) 2011.  [(accessed on 8 February 2023)].  Available online:  https://apps.who.int/iris/handle/10665/207490?locale-attribute=en&amp;.</Citation></Reference><Reference><Citation>van der Avoort H.G., Hull B.P., Hovi T., A Pallansch M., Kew O.M., Crainic R., Wood D.J., Mulders M.N., van Loon A.M. Comparative study of five methods for intratypic differentiation of polioviruses. J. Clin. Microbiol. 1995;33:2562–2566. doi: 10.1128/jcm.33.10.2562-2566.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.33.10.2562-2566.1995</ArticleId><ArticleId IdType="pmc">PMC228529</ArticleId><ArticleId IdType="pubmed">8567883</ArticleId></ArticleIdList></Reference><Reference><Citation>Crainic R., Couillin P., Blondel B., Cabau N., Boué A., Horodniceanu F. Natural variation of poliovirus neutralization epitopes. Infect. Immun. 1983;41:1217–1225. doi: 10.1128/iai.41.3.1217-1225.1983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.41.3.1217-1225.1983</ArticleId><ArticleId IdType="pmc">PMC264629</ArticleId><ArticleId IdType="pubmed">6193066</ArticleId></ArticleIdList></Reference><Reference><Citation>Nix W.A., Oberste M.S., Pallansch M.A. Sensitive, Seminested PCR Amplification of VP1 Sequences for Direct Identification of All Enterovirus Serotypes from Original Clinical Specimens. J. Clin. Microbiol. 2006;44:2698–2704. doi: 10.1128/JCM.00542-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00542-06</ArticleId><ArticleId IdType="pmc">PMC1594621</ArticleId><ArticleId IdType="pubmed">16891480</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste M.S., Maher K., Williams A.J., Dybdahl-Sissoko N., Brown B.A., Gookin M.S., Peñaranda S., Mishrik N., Uddin M., Pallansch M.A. Species-specific RT-PCR amplification of human enteroviruses: A tool for rapid species identification of uncharacterized enteroviruses. J. Gen. Virol. 2006;87:119–128. doi: 10.1099/vir.0.81179-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81179-0</ArticleId><ArticleId IdType="pubmed">16361424</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Stecher G., Tamura K. MEGA 7: Molecular Evolutionary Genetics Analysis version 7.0. Mol. Biol. and Evol. 2016;33:1870–1874. doi: 10.1093/molbev/msw054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msw054</ArticleId><ArticleId IdType="pmc">PMC8210823</ArticleId><ArticleId IdType="pubmed">27004904</ArticleId></ArticleIdList></Reference><Reference><Citation>Böttcher S., Diedrich S., Keeren K., the Laboratory Network for Enterovirus Diagnostic (LaNED) Increased detection of enterovirus A71 infections, Germany, 2019. Eurosurveillance. 2019;24:1900556. doi: 10.2807/1560-7917.ES.2019.24.39.1900556.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.39.1900556</ArticleId><ArticleId IdType="pmc">PMC6774229</ArticleId><ArticleId IdType="pubmed">31576805</ArticleId></ArticleIdList></Reference><Reference><Citation>Van N.T.T., Nguyen V.T.T., Nguyen Q.H., Pham D.T. Molecular epidemiology analysis of enterovirus 71 strains isolated in Dak Lak, Vietnam, 2011–2016. J. Med. Virol. 2019;91:56–64. doi: 10.1002/jmv.25286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25286</ArticleId><ArticleId IdType="pubmed">30132913</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Pham H., Hoang T.N.A., Duong H.T., Phan L.T., Phan U.T.N., Ho N.X., Hoang C.Q. Clinical characteristics of hand, foot and mouth disease in Daklak Province, Vietnam and associated factors of severe cases. Virusdisease. 2017;28:430–433. doi: 10.1007/s13337-017-0402-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-017-0402-8</ArticleId><ArticleId IdType="pmc">PMC5747846</ArticleId><ArticleId IdType="pubmed">29291236</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J., Auphimai C., Korkong S., Vongpunsawad S., Poovorawan Y. Enterovirus A71 Infection, Thailand, 2017. Emerg. Infect. Dis. 2018;24:1386–1387. doi: 10.3201/eid2407.171923.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2407.171923</ArticleId><ArticleId IdType="pmc">PMC6038748</ArticleId><ArticleId IdType="pubmed">29912701</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang C.Q., Nguyen T.T.T., Ho N.X., Nguyen H.D., Nguyen A.B., Nguyen T.H.T., Phan H.C., Phan L.T. Transmission and serotype features of hand foot mouth disease in household contacts in Dong Thap, Vietnam. BMC Infect. Dis. 2019;19:933. doi: 10.1186/s12879-019-4583-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-4583-1</ArticleId><ArticleId IdType="pmc">PMC6833133</ArticleId><ArticleId IdType="pubmed">31690269</ArticleId></ArticleIdList></Reference><Reference><Citation>Nhan L.N.T., Khanh T.H., Hong N.T.T., Van H.M.T., Nhu L.N.T., Ny N.T.H., Nguyet L.A., Thanh T.T., Anh N.T., Hang V.T.T., et al. Clinical, etiological and epidemio-logical investigations of hand, foot and mouth disease in southern Vietnam during 2015–2018. PLoS Negl. Trop. Dis. 2020;14:e0008544. doi: 10.1371/journal.pntd.0008544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0008544</ArticleId><ArticleId IdType="pmc">PMC7451980</ArticleId><ArticleId IdType="pubmed">32804980</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang C.Q., Nguyen H.D., Ho N.X., Vu T.H.T., Pham T.T.M., Nguyen K.T., Hoang L.T., Clapham H., Nguyen T.T.T., Phan L.T. Incidence of Infection of Enterovirus 71 and Coxsackieviruses A6 and A16 among Household Contacts of Index Cases in Dong Thap Province, Southern Vietnam. BioMed Res. Int. 2020;2020:9850351. doi: 10.1155/2020/9850351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/9850351</ArticleId><ArticleId IdType="pmc">PMC7695493</ArticleId><ArticleId IdType="pubmed">33274234</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hoang M.T., Nguyen T.A., Tran T.T., Vu T.T.H., Le N.T.N., Nguyen T.H.N., Le T.H.N., Nguyen T.T.H., Nguyen T.H., Le N.T.N., et al. Clinical and aetiological study of hand, foot and mouth disease in southern Vietnam, 2013–2015: Inpatients and outpatients. Int. J. Infect. Dis. 2019;80:1–9. doi: 10.1016/j.ijid.2018.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2018.12.004</ArticleId><ArticleId IdType="pmc">PMC6403263</ArticleId><ArticleId IdType="pubmed">30550944</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q., Cheng T., Zhu F., Li J., Wang Y., Li Y., Gao F., Yang L., Yao X., Shao J., et al. The Cross-Neutralizing Activity of Enterovirus 71 Subgenotype C4 Vaccines in Healthy Chinese Infants and Children. PLoS ONE. 2013;8:e79599. doi: 10.1371/journal.pone.0079599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079599</ArticleId><ArticleId IdType="pmc">PMC3834186</ArticleId><ArticleId IdType="pubmed">24260259</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., Xu W., Xia J., Liang Z., Liu Y., Zhang X., Tan X., Wang L., Mao Q., Wu J., et al. Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China. N. Engl. J. Med. 2014;370:829–832. doi: 10.1056/NEJMoa1304923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F.C., Meng F.Y., Li J.X., Li X.L., Mao Q.Y., Tao H., Zhang Y.T., Yao X., Chu K., Chen Q.H., et al. Efficacy, safety, and immunology of an inactivated al-um-adjuvant enterovirus 71 vaccine in children in China: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381:2024–2032. doi: 10.1016/S0140-6736(13)61049-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61049-1</ArticleId><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.T., Chiu C.-H., Lin C.-Y., Chiu N.-C., Chen P.-Y., Le T.T.V., Le D.N., Duong A.H., Nguyen V.L., Huynh T.N., et al. Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: A multiregion, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 2022;399:1708–1717. doi: 10.1016/S0140-6736(22)00313-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00313-0</ArticleId><ArticleId IdType="pubmed">35427481</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L.M., Chiu C.H., Chiu N.C., Lin C.Y., Li M.T., Kuo T.Y., Weng Y.J., Hsieh E.F., Tai I.C. Immunogenicity, safety, cross-reaction, and im-mune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan. Vaccines. 2019;37:1827–1835. doi: 10.1016/j.vaccine.2019.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.02.023</ArticleId><ArticleId IdType="pubmed">30803843</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  Recommendations to Assure the Quality, Safety and Efficacy of Enterovirus 71 Vaccines (Inactivated) 2020.  [(accessed on 8 February 2023)].  Available online:  https://www.who.int/publications/m/item/ev71-recommendationsdocs/default-source/biologicals/ecbs/post-ecbs-who-ev71-vaccinesrecommendations-final-3-nov-2020.pdf?sfvrsn=ce2ba6b5.</Citation></Reference><Reference><Citation>World Health Organization (WHO)  List of Blueprint Priority Diseases. February 2018—Second Annual Review.  [(accessed on 8 February 2023)].  Available online:  https://www.who.int/blueprint/priority-diseases/en/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>